StockData
Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc. (CLDX) stock

CLDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$28.04−0.55 (-1.92%)

Close on Nov 17, 2026Market cap $2.20BP/E –Yield –

Celldex Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Celldex Therapeutics's market cap was $2.37B on Nov 11, 2026, against $1.80B a year earlier. Over the last 5 years it ranged from $1.10B to $3.11B, with a median of $1.72B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.37B+31.1%
2025Dec 31, 2025$1.80B+7.6%
2024Dec 31, 2024$1.68B-10.6%
2023Dec 29, 2023$1.87B-10.7%
2022Dec 30, 2022$2.10B+16.4%
2021Dec 31, 2021$1.80B+160.1%
2020Dec 31, 2020$693.13M+1854.3%
2019Dec 31, 2019$35.47M+5.2%
2018Dec 31, 2018$33.72M-91.0%
2017Dec 29, 2017$375.17M+4.7%
2016Dec 30, 2016$358.40M-76.8%
2015Dec 31, 2015$1.55B-5.2%
2014Dec 31, 2014$1.63B-16.9%
2013Dec 31, 2013$1.96B+381.3%
2012Dec 31, 2012$408.02M+255.5%
2011Dec 30, 2011$114.78M+40.5%
2010Dec 31, 2010$81.67M–

More Celldex Therapeutics figures

See a number that looks wrong?